Year-End Cheer For Glenmark As Ryaltris To Debut In Australia

 
• By Anju Ghangurde

Glenmark is ending 2019 on a buoyant note, with its rhinitis therapy getting the go-ahead in Australia. Though not seen as a huge commercial opportunity in the island continent, the clearance augurs well for the product’s overall trajectory.

3D_Australia
Australia To Be First Market Globally For Ryaltris • Source: Shutterstock

More from Focus On Asia

More from Scrip